Profiling the metabolic difference of seven tanshinones using high‐performance liquid chromatography/multi‐stage mass spectrometry with data‐dependent acquisition
Authors:
- 14 June 2007
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 21 (14) , 2211-2226
Abstract
Tanshinones are a class of bioactive constituents in the roots of Salvia miltiorrhiza named Dan‐Shen in Chinese, which possess diverse pharmacological activities. In this study, we employed a sensitive high‐performance liquid chromatography/multi‐stage mass spectrometry (HPLC/MS n ) method with data‐dependent acquisition and a dynamic exclusion program for the identification of phase I metabolites of seven tanshinones in rat bile after intravenous administration. These seven tanshinones are tanshinone IIA, sodium tanshinone IIA sulfonate (abbreviated as STS, a water‐soluble derivate of tanshinone IIA), cryptotanshinone, 15,16‐dihydrotanshinone I, tanshinone IIB, przewaquinone A and tanshinone I. Altogether 33 metabolites underwent monohydroxylation, dihydroxylation, dehydrogenation, D‐ring hydrolysis or oxidation reactions in the C‐4 or C‐15 side chain which were characterized by analyzing the LC/MS n data. Different metabolic reactions for tanshinones were dependent on the degree of saturation and the substituent group in the skeleton. Dehydrogenation was the major metabolic modification for cryptotanshinone with saturated A and D rings. 15,16‐Dihydrotanshinone I containing a saturated D ring was mainly metabolized through D‐ring hydrolysis. For tanshinone IIA, possessing a saturated A ring, hydroxylation was the major metabolic pathway. When there was hydroxyl group substitution in the C‐17 or C‐18 position, such as przewaquinone A and tanshinone IIB, or sulfonic group substitution in the C‐16 position, such as STS, higher metabolic stability than that of tanshinone IIA was shown and only trace metabolites were generated. Oxidation in the C‐4 or C‐15 side chain was a characteristic reaction for tanshinone IIA and hydroxylated tanshinone IIA. For tanshinone I, bearing unsaturated A and D rings simultaneously, no metabolites were detected. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 25 references indexed in Scilit:
- Identification of tanshinones and their metabolites in rat bile after oral administration of TTE-50, a standardized extract of Salvia miltiorrhiza by HPLC–ESI–DAD–MSnJournal of Pharmaceutical and Biomedical Analysis, 2006
- Pharmacokinetics, Absorption and Tissue Distribution of Tanshinone IIA Solid DispersionPlanta Medica, 2006
- Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometryJournal of Mass Spectrometry, 2006
- Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC–MS/MS)Journal of Pharmaceutical and Biomedical Analysis, 2006
- In vivo metabolite detection and identification in drug discovery via LC‐MS/MS with data‐dependent scanning and postacquisition data miningJournal of Mass Spectrometry, 2005
- Identification of flavonoids using liquid chromatography with electrospray ionization and ion trap tandem mass spectrometry with an MS/MS libraryRapid Communications in Mass Spectrometry, 2005
- Determination of cryptotanshinone and its metabolite in rat plasma by liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2005
- Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarctionLife Sciences, 2005
- Simultaneous measurement of metabolic stability and metabolite identification of 7‐methoxymethylthiazolo[3,2‐a]pyrimidin‐5‐one derivatives in human liver microsomes using liquid chromatography/ion‐trap mass spectrometryRapid Communications in Mass Spectrometry, 2005
- L 1→L q Poincaré Inequalities for 0 < q < 1 Imply Representation FormulasActa Mathematica Sinica, English Series, 2002